Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
scientific article
Author/s
author: Hagop Kantarjian, Stefan Faderl, Srdan Verstovsek, William G Wierda, Jorge Eduardo Cortes, Susan O'Brien, Elias Jabbour, Mary Beth Rios, Guillermo Garcia-Manero, Jenny Pui Shan Wong, Neeli Reddy
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.